Plinabulin Boosts Dendritic Cell Growth, Fights Tumors After Checkpoint Inhibitor Failure
A recent study published in •Med• revealed that Plinabulin, in combination with radiation and PD-1 inhibitors, shows promise in...
eClinical Tech News
Chemomab Announces Positive Nebokitug Phase 2 Clinical Data in PSC at BSG ‘25
Chemomab Therapeutics announced positive Phase 2 SPRING trial data for nebokitug (CM-101) in patients with primary sclerosing cholangitis (PSC)...
Assembly Biosciences Doses First Participant in Phase 1b Trial of Herpes Simplex Virus Inhibitor
Assembly Biosciences has dosed the first participant in a Phase 1b study of ABI-1179, an oral, long-acting herpes simplex...
Leronlimab Shows Encouraging Survival Data in Metastatic Colorectal Cancer Patients
CytoDyn announced encouraging clinical findings from a compassionate use study of leronlimab in patients with advanced metastatic colorectal cancer...
Zervimesine Alzheimer’s Study Surpasses 50% Enrollment
Cognition Therapeutics announced that its Phase 2 START Study for Alzheimer’s disease has surpassed 50% enrollment. The study, conducted...
BioXcel Therapeutics Gets Positive Recommendation for Serenity Trial
BioXcel Therapeutics’ independent Data Safety Monitoring Board (DSMB) recommended the continuation of the SERENITY At-Home Phase 3 safety trial...
Positive Phase 2B Results for Treatment-Resistant Depression
Atai Life Sciences and Beckley Psytech announced positive topline results from a Phase 2b trial of BPL-003 (intranasal mebufotenin)...
UK MHRA Approves First-in-Human Trial of RinCell-1 for Hearing Loss
Rinri Therapeutics received approval from the UK MHRA to begin its first-in-human clinical trial for Rincell-1, a regenerative cell...
ReproNovo’s RPN-001 Enters US Phase 2 Trial for Male Infertility
ReproNovo has initiated a Phase 2 clinical trial for RPN-001 (leflutrozole), an oral aromatase inhibitor designed to treat male...
Invivyd & SPEAR Study Group Launch Long COVID Monoclonal Antibody Therapy Research
Invivyd formed the SPEAR Study Group to investigate the potential of monoclonal antibody therapy for Long COVID and Post-Vaccination...